(3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents

Masahiro Nomura, Susumu Kinoshita, Hiroya Satoh, Toshio Maeda, Koji Murakami, Masaki Tsunoda, Hiroyuki Miyachi, Katsuya Awano

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

A series of 3-[(2,4-dioxothiazolidin-5-yl)methyl]benzamide derivatives was prepared as part of a search for antidiabetic agents. A structure- activity relationship study of these compounds led to the identification of 5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[4- (trifluoromethyl)phenyl]methyl]benzamide (KRP-297) as a candidate drug for the treatment of diabetes mellitus.

Original languageEnglish
Pages (from-to)533-538
Number of pages6
JournalBioorganic and Medicinal Chemistry Letters
Volume9
Issue number4
DOIs
Publication statusPublished - Feb 22 1999

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of '(3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents'. Together they form a unique fingerprint.

  • Cite this

    Nomura, M., Kinoshita, S., Satoh, H., Maeda, T., Murakami, K., Tsunoda, M., Miyachi, H., & Awano, K. (1999). (3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents. Bioorganic and Medicinal Chemistry Letters, 9(4), 533-538. https://doi.org/10.1016/S0960-894X(99)00039-6